FDA amends animal drug regulations
The FDA is amending the animal drug regulations to reflect approval of a new animal drug application filed by Intervet, Inc. The NADA provides for the veterinary prescription use of a suspension containing orbifloxacin, mometasone furoate monohydrate, and posaconazole for the treatment of otitis externa in dogs.
FDA approval or clearance is never enough.